Arvind Bambhroliya

Arvind Bambhroliya

Auto-generated profile, based on publicly available information

Arvind Bambhroliya

The Institute of Stroke and Cerebrovascular Diseases and The Department of Neurology, McGovern Medical School at University of Texas Health Science Center, Houston, Texas, United States of America

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
26 December 2012 in International Journal of Stroke
Verified
Journal Article
Closed access
PSPreeti Sahota
Preeti Sahota
FVFarhaan Vahidy
Farhaan Vahidy
CNClaude Nguyen
Claude Nguyen
TBThanh-Tung Bui
Thanh-Tung Bui
BYBing Yang
Bing Yang
SSSean Savitz
Sean Savitz

31 January 2012 in Journal of Environmental and Public Health
Verified
Journal Article
Open access
PDF file
ABArvind B. Bambhroliya
Arvind B. Bambhroliya
KBKeith D. Burau
Keith D. Burau
KSKen Sexton
Ken Sexton
Objective. The objectives of the study were to detect high-risk areas and to examine how racial and ethnic status affect the geographic distribution of female breast cancer mortality in Texas. Analyses were based on county-level data for the years from 2000 to 2008.Materials and Methods. Breast cancer mortality data were obtained from the Texas Cancer Registry, and the Spatial Scan Statistics method was used to run Purely Spatial Analyses using the Discrete Poisson, Bernoulli, and Multinomial models.Results and Conclusions. Highest rates of female breast cancer mortality in Texas have shifted over time from southeastern areas towards northern and eastern areas, and breast cancer mortality at the county level is distributed heterogeneously based on racial/ethnic status. Non-Hispanic blacks were at highest risk in the northeastern region and lowest risk in the southern region, while Hispanics were at highest risk in the southern region along the border with Mexico and lowest risk in the northeastern region.

14 November 2019 in PLOS ONE
Verified
Journal Article
Open access
PDF file
FVFarhaan S Vahidy
Farhaan S Vahidy
ABArvind B Bambhroliya
Arvind B Bambhroliya
JMJennifer R Meeks
Jennifer R Meeks
OROmar Rahman
Omar Rahman
EEE Wesley Ely
E Wesley Ely
BKBabar Khan
Babar Khan
Delirium is associated with poor outcomes among critically ill patients. However, it is not well characterized among patients with ischemic or hemorrhagic stroke (IS and HS). We provide the population-level frequency of in-hospital delirium and assess its association with in-hospital outcomes and with 30-day readmission among IS and HS patients. We analyzed Nationwide in-hospital and readmission data for years 2010–2015 and identified stroke patients using ICD-9 codes. Delirium was identified using validated algorithms. Outcomes were in-hospital mortality, length of stay, unfavorable discharge disposition, and 30-day readmission. We used survey design logistic regression methods to provide national estimates of proportions and 95% confidence intervals (CI) for delirium, and odds ratios (OR) for association between delirium and poor outcomes. We identified 3,107,437 stroke discharges of whom 7.45% were coded to have delirium. This proportion significantly increased between 2010 (6.3%) and 2015 (8.7%) (aOR, 95% CI: 1.04, 1.03–1.05). Delirium proportion was higher among HS patients (ICH: 10.0%, SAH: 9.8%) as compared to IS patients (7.0%). Delirious stroke patients had higher in-hospital mortality (12.3% vs. 7.8%), longer in-hospital stay (11.6 days vs. 7.3 days) and a significantly greater adjusted risk of 30-day-readmission (16.7%) as compared to those without delirium (12.2%) (aRR, 95% CI: 1.13, 1.11–1.15). Upon readmission, patients with delirium at initial admission continued to have a longer length of stay (7.7 days vs. 6.6 days) and a higher in-hospital mortality (9.3% vs. 6.4%). Delirium identified through claims data in stroke patients is independently associated with poor in-hospital outcomes both at index admission and readmission. Identification and management of delirium among stroke patients provides an opportunity to improve outcomes.

1 January 2013 in Methodist DeBakey Cardiovascular Journal
Verified
Journal Article
Open access
TSTina Shah
Tina Shah
SASameer Ather
Sameer Ather
CBChirag Pankajkumar Bavishi
Chirag Pankajkumar Bavishi
ABArvind Bambhroliya
Arvind Bambhroliya
TMTony Ma
Tony Ma
BBBiykem Bozkurt
Biykem Bozkurt
Peripartum cardiomyopathy is a rare and potentially fatal disease. Though approximately half of the patients recover, the clinical course is highly variable and some patients develop refractory heart failure and persistent left ventricular systolic dysfunction. It is diagnosed when women present with heart failure secondary to left ventricular systolic dysfunction towards the end of pregnancy or in the months following delivery, where no other cause of heart failure is found. Etiology remains unclear, and treatment is similar to other cardiomyopathies and includes evidence-based standard heart failure management strategies. Experimental strategies such as intravenous immunoglobulin and bromocriptine await further clinical validation.